{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:03:11Z","timestamp":1790758991458,"version":"4.1.0"},"reference-count":98,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Musculoskeletal disease is one of the major determinants of long-term morbidity in acromegaly, yet traditionally its pathophysiology and clinical management have been addressed through separate perspectives on skeletal fragility and arthropathy. Recent advances in skeletal biology, imaging, and biomechanics, as well as longitudinal clinical studies support a broader interpretation of acromegalic osteoarthropathy as a disorder of pathological musculoskeletal remodeling involving coordinated alterations of bone, joints, muscle, and body composition. In this review, we propose an integrative conceptual framework that brings together current evidence on the biological mechanisms underlying musculoskeletal remodeling, the clinical phenotype of active disease and the long-term consequences that frequently persist despite successful endocrine treatment. We discuss the strengths and limitations of currently available diagnostic approaches, including assessment of bone quality, vertebral fractures, arthropathy, and spinal biomechanics, and examine the clinical determinants of fracture risk beyond conventional bone mineral density evaluation. Particular emphasis is placed on the transition from endocrine-centered care to phenotype-driven management, highlighting current evidence regarding long-term surveillance, disease modification, and multidisciplinary management of persistent musculoskeletal disability. Collectively, the available evidence indicates that bone fragility, arthropathy, muscle dysfunction, and altered body composition should no longer be considered solely as isolated complications but may be interpreted as biologically related manifestations within a shared framework of pathological musculoskeletal remodeling. This integrated framework provides a biologically coherent interpretation of acromegalic osteoarthropathy and has important implications for individualized patient care, future translational research, and the development of disease-modifying therapeutic strategies aimed at preserving lifelong musculoskeletal health.<\/jats:p>","DOI":"10.1093\/ejendo\/lvag178","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:49:45Z","timestamp":1789127385000},"page":"R97-R107","source":"Crossref","is-referenced-by-count":0,"title":["Acromegalic osteoarthropathy: a new paradigm of pathological musculoskeletal remodeling"],"prefix":"10.1093","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5458-701X","authenticated-orcid":false,"given":"Gherardo","family":"Mazziotti","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University , Via Rita Levi Montalcini 4, Pieve Emanuele, Milan 20072 ,","place":["Italy"]},{"name":"Osteoporosis Section, Endocrinology, Diabetology and Andrology Unit, IRCCS Humanitas Research Hospital , Via Manzoni 56, Milan 20089 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6525-0439","authenticated-orcid":false,"given":"Salvatore","family":"Minisola","sequence":"additional","affiliation":[{"name":"Department of Medical and Cardiovascular Sciences, \u201cSapienza\u201d University of Rome , Viale del Policlinico 155, Rome 00161 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9154-952X","authenticated-orcid":false,"given":"Ernesto","family":"Canalis","sequence":"additional","affiliation":[{"name":"Departments of Orthopaedic Surgery and Medicine UConn Musculoskeletal Institute, UConn Health , Farmington, CT 06030 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"issue":"11","key":"2026093004253327800_lvag178-B1","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/s2213-8587(22)00244-3","article-title":"Acromegaly: pathogenesis, diagnosis, and management","volume":"10","author":"Fleseriu","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"2026093004253327800_lvag178-B2","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s11102-019-00966-8","article-title":"Arthropathy in acromegaly: a questionnaire-based estimation of motor disability and its relation with quality of life and work productivity","volume":"22","author":"Fatti","year":"2019","journal-title":"Pituitary"},{"issue":"8","key":"2026093004253327800_lvag178-B3","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1159\/000511811","article-title":"Vertebral fractures associated with spinal sagittal imbalance and quality of life in acromegaly: a radiographic study with EOS 2D\/3D technology","volume":"111","author":"Cellini","year":"2021","journal-title":"Neuroendocrinology"},{"issue":"2","key":"2026093004253327800_lvag178-B4","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1093\/ejendo\/lvad090","article-title":"Joint pain, physical function, and balance self-confidence in acromegaly versus nonfunctioning pituitary adenoma patients","volume":"189","author":"Title","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026093004253327800_lvag178-B5","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/ejendo\/lvag047","article-title":"Progression of acromegalic joint and psychological complications according to sex, treatments, and disease control","volume":"194","author":"Cangiano","year":"2026","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2026093004253327800_lvag178-B6","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1530\/eje-10-1005","article-title":"High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly","volume":"164","author":"Wassenaar","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2026093004253327800_lvag178-B7","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1210\/jc.2012-4073","article-title":"Acromegaly has a negative influence on trabecular bone, but not on cortical bone, as assessed by high-resolution peripheral quantitative computed tomography","volume":"98","author":"Madeira","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026093004253327800_lvag178-B8","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1210\/jc.2014-2937","article-title":"Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis","volume":"100","author":"Mazziotti","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026093004253327800_lvag178-B9","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1530\/eje-17-0468","article-title":"Bone microarchitecture and estimated bone strength in men with active acromegaly","volume":"177","author":"Silva","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2026093004253327800_lvag178-B10","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3803\/EnM.2023.1782","article-title":"Increased risk of hip fracture in patients with acromegaly: a nationwide cohort study in Korea","volume":"38","author":"Kim","year":"2023","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"9","key":"2026093004253327800_lvag178-B11","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s00198-023-06800-z","article-title":"Acromegaly and the long-term fracture risk of the vertebra and hip: a national cohort study","volume":"34","author":"Kwon","year":"2023","journal-title":"Osteoporos Int"},{"issue":"7","key":"2026093004253327800_lvag178-B12","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s40618-023-02056-w","article-title":"Bone quality in endocrine diseases: determinants and clinical relevance","volume":"46","author":"Cianferotti","year":"2023","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2026093004253327800_lvag178-B13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000375450","article-title":"Bone and joint disorders in acromegaly","volume":"103","author":"Claessen","year":"2016","journal-title":"Neuroendocrinology"},{"issue":"4","key":"2026093004253327800_lvag178-B14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1530\/EJE-20-0415","article-title":"Progression of vertebral fractures in long-term controlled acromegaly: a 9-year follow-up study","volume":"183","author":"Pelsma","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2026093004253327800_lvag178-B15","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvad121","article-title":"Persistent deficits in bone quality in treated acromegaly: evidence from assessments of microstructure","volume":"7","author":"Kuker","year":"2023","journal-title":"J Endocr Soc"},{"issue":"6","key":"2026093004253327800_lvag178-B16","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvae079","article-title":"Long-term pegvisomant therapy of acromegaly: effects on bone density, turnover and microstructure using HRpQCT","volume":"8","author":"Kuker","year":"2024","journal-title":"J Endocr Soc"},{"issue":"3","key":"2026093004253327800_lvag178-B17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s11102-026-01639-z","article-title":"Consensus on acromegaly complications: an update","volume":"29","author":"Giustina","year":"2026","journal-title":"Pituitary"},{"issue":"Supplement_1","key":"2026093004253327800_lvag178-B18","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1210\/clinem\/dgag114","article-title":"Acromegaly complications: an update","volume":"111","author":"Giustina","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026093004253327800_lvag178-B19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41574-022-00649-8","article-title":"Skeletal disorders associated with the growth hormone-insulin-like growth factor 1 axis","volume":"18","author":"Mazziotti","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"2026093004253327800_lvag178-B20","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1172\/jci109908","article-title":"Effect of insulinlike growth factor I on DNA and protein synthesis in cultured rat calvaria","volume":"66","author":"Canalis","year":"1980","journal-title":"J Clin Invest"},{"issue":"2","key":"2026093004253327800_lvag178-B21","doi-asserted-by":"publisher","first-page":"186","DOI":"10.4248\/br201302007","article-title":"IGF-1 Signaling is essential for differentiation of mesenchymal stem cells for peak bone mass","volume":"1","author":"Crane","year":"2013","journal-title":"Bone Res"},{"issue":"3","key":"2026093004253327800_lvag178-B22","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1530\/eje.1.01874","article-title":"GH\/IGF-I and bone resorption in vivo and in vitro","volume":"152","author":"Ueland","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026093004253327800_lvag178-B23","doi-asserted-by":"publisher","first-page":"249","DOI":"10.4248\/br201303003","article-title":"Autocrine and paracrine actions of IGF-I signaling in skeletal development","volume":"1","author":"Wang","year":"2013","journal-title":"Bone Res"},{"issue":"26","key":"2026093004253327800_lvag178-B24","doi-asserted-by":"publisher","first-page":"15353","DOI":"10.1016\/S0021-9258(18)55399-0","article-title":"Cyclic AMP induces insulin-like growth factor I synthesis in osteoblast-enriched cultures","volume":"265","author":"McCarthy","year":"1990","journal-title":"J Biol Chem"},{"issue":"20","key":"2026093004253327800_lvag178-B25","doi-asserted-by":"publisher","first-page":"9826","DOI":"10.1073\/pnas.89.20.9826","article-title":"Growth hormone induces multiplication of the slowly cycling germinal cells of the rat tibial growth plate","volume":"89","author":"Ohlsson","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2026093004253327800_lvag178-B26","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1359\/jbmr.060610","article-title":"Role of IGF-I signaling in regulating osteoclastogenesis","volume":"21","author":"Wang","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2026093004253327800_lvag178-B27","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1359\/jbmr.1998.13.4.706","article-title":"Systemic over-secretion of growth hormone in transgenic mice results in a specific pattern of skeletal modeling and adaptation","volume":"13","author":"Tseng","year":"1998","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2026093004253327800_lvag178-B28","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1530\/EJE-17-0772","article-title":"Effects of active acromegaly on bone mRNA and microRNA expression patterns","volume":"178","author":"Belaya","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026093004253327800_lvag178-B29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11102-017-0847-1","article-title":"Bone histomorphometry in acromegaly patients with fragility vertebral fractures","volume":"21","author":"Dalle Carbonare","year":"2018","journal-title":"Pituitary"},{"issue":"9","key":"2026093004253327800_lvag178-B30","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1210\/clinem\/dgab260","article-title":"Impaired bone microarchitecture in premenopausal women with acromegaly: the possible role of Wnt signaling","volume":"106","author":"Silva","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026093004253327800_lvag178-B31","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1530\/erc-17-0523","article-title":"Runx2 overexpression compromises bone quality in acromegalic patients","volume":"25","author":"Valenti","year":"2018","journal-title":"Endocr Relat Cancer"},{"issue":"10","key":"2026093004253327800_lvag178-B32","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nrendo.2013.154","article-title":"Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches","volume":"9","author":"Canalis","year":"2013","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"2026093004253327800_lvag178-B33","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s40618-025-02733-y","article-title":"Role of Notch signaling in corticalization","volume":"49","author":"Mazziotti","year":"2026","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2026093004253327800_lvag178-B34","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz254","article-title":"Increased serum sclerostin levels in patients with active acromegaly","volume":"105","author":"Pekkolay","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026093004253327800_lvag178-B35","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.ajpath.2023.02.010","article-title":"Excess growth hormone triggers inflammation-associated arthropathy, subchondral bone loss, and arthralgia","volume":"193","author":"Poudel","year":"2023","journal-title":"Am J Pathol"},{"issue":"7","key":"2026093004253327800_lvag178-B36","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/art.42470","article-title":"Promotion of joint degeneration and chondrocyte metabolic dysfunction by excessive growth hormone in mice","volume":"75","author":"Zhu","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"2026093004253327800_lvag178-B37","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1210\/jc.2015-1917","article-title":"Adipose tissue redistribution and ectopic lipid deposition in active acromegaly and effects of surgical treatment","volume":"100","author":"Reyes-Vidal","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026093004253327800_lvag178-B38","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1210\/jc.2017-01210","article-title":"Body composition and ectopic lipid changes with biochemical control of acromegaly","volume":"102","author":"Bredella","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026093004253327800_lvag178-B39","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1530\/eje-21-0900","article-title":"Treatment of acromegaly has substantial effects on body composition: a long-term follow-up study","volume":"186","author":"Wolf","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"2026093004253327800_lvag178-B40","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1007\/s40618-025-02624-2","article-title":"Sarcopenic obesity and physical function in acromegaly: impact of disease control and evaluation using dual X-ray absorptiometry and multifrequency bioelectrical impedance analysis","volume":"48","author":"Inojosa","year":"2025","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2026093004253327800_lvag178-B41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11102-024-01494-w","article-title":"Assessment of sarcopenic obesity in patients with acromegaly","volume":"28","author":"Rocha","year":"2025","journal-title":"Pituitary"},{"issue":"3","key":"2026093004253327800_lvag178-B42","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11102-025-01539-8","article-title":"Muscle dysfunction is associated with poor quality of life in long-term controlled patients with acromegaly","volume":"28","author":"Martel-Duguech","year":"2025","journal-title":"Pituitary"},{"issue":"4","key":"2026093004253327800_lvag178-B43","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.3390\/ijms21041178","article-title":"Bone control of muscle function","volume":"21","author":"Battafarano","year":"2020","journal-title":"Int J Mol Sciences"},{"issue":"5","key":"2026093004253327800_lvag178-B44","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1359\/jbmr.2003.18.5.836","article-title":"Paracrine overexpression of IGFBP-4 in osteoblasts of transgenic mice decreases bone turnover and causes global growth retardation","volume":"18","author":"Zhang","year":"2003","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2026093004253327800_lvag178-B45","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1002\/jbmr.2282","article-title":"IGFBP-2 directly stimulates osteoblast differentiation","volume":"29","author":"Xi","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2026093004253327800_lvag178-B46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2203779120","article-title":"Bone marrow-derived IGF-1 orchestrates maintenance and regeneration of the adult skeleton","volume":"120","author":"Wang","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2026093004253327800_lvag178-B47","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1046\/j.1365-2362.2002.00944.x","article-title":"Decreased trabecular bone biomechanical competence, apparent density, IGF-II and IGFBP-5 content in acromegaly","volume":"32","author":"Ueland","year":"2002","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"2026093004253327800_lvag178-B48","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s12020-016-1078-3","article-title":"High-resolution-cone beam tomography analysis of bone microarchitecture in patients with acromegaly and radiological vertebral fractures","volume":"54","author":"Maffezzoni","year":"2016","journal-title":"Endocrine"},{"issue":"6","key":"2026093004253327800_lvag178-B49","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.jbspin.2020.04.020","article-title":"Acromegaly is associated with vertebral deformations but not vertebral fractures: results of a cross-sectional monocentric study","volume":"87","author":"Plard","year":"2020","journal-title":"Joint Bone Spine"},{"issue":"4","key":"2026093004253327800_lvag178-B50","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.tem.2020.01.011","article-title":"Acromegaly and vertebral fractures: facts and questions","volume":"31","author":"Giustina","year":"2020","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"2026093004253327800_lvag178-B51","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1530\/eje-18-0881","article-title":"Non-invasive DXA-derived bone structure assessment of acromegaly patients: a cross-sectional study","volume":"180","author":"Kuzma","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2026093004253327800_lvag178-B52","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10240","article-title":"Hip structure analyses in acromegaly: decrease of cortical bone thickness after treatment: a longitudinal cohort study","volume":"3","author":"Godang","year":"2019","journal-title":"JBMR Plus"},{"issue":"12","key":"2026093004253327800_lvag178-B53","doi-asserted-by":"publisher","first-page":"e5088","DOI":"10.1210\/clinem\/dgab259","article-title":"Vertebral fractures occur despite control of acromegaly and are predicted by cortical volumetric bone mineral density","volume":"106","author":"Kuzma","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026093004253327800_lvag178-B54","doi-asserted-by":"publisher","first-page":"395\u2013","DOI":"10.1159\/000528199","article-title":"Trabecular bone score as an index of bone fragility in patients with acromegaly: a systematic review and meta-analysis","volume":"113","author":"Bioletto","year":"2023","journal-title":"Neuroendocrinology"},{"issue":"10","key":"2026093004253327800_lvag178-B55","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10787","article-title":"Endocortical trabecularization in acromegaly: the cause for the paradoxically increased vertebral fracture risk?","volume":"7","author":"Heck","year":"2023","journal-title":"JBMR Plus"},{"issue":"3","key":"2026093004253327800_lvag178-B56","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1530\/eje-16-0808","article-title":"Bone material strength index as measured by impact microindentation is altered in patients with acromegaly","volume":"176","author":"Malgo","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2026093004253327800_lvag178-B57","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1007\/s11102-022-01256-6","article-title":"Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis","volume":"25","author":"Ribeiro de Moura","year":"2022","journal-title":"Pituitary"},{"issue":"10","key":"2026093004253327800_lvag178-B58","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1359\/jbmr.050603","article-title":"Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women","volume":"20","author":"Bonadonna","year":"2005","journal-title":"J Bone Miner Res"},{"issue":"8","key":"2026093004253327800_lvag178-B59","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1210\/jc.2013-1460","article-title":"Vertebral fractures in patients with acromegaly: a 3-year prospective study","volume":"98","author":"Mazziotti","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026093004253327800_lvag178-B60","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/ejendo\/lvaf047","article-title":"Musculoskeletal disease in acromegaly-a population-based registry study","volume":"192","author":"Rosendal","year":"2025","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"2026093004253327800_lvag178-B61","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1007\/s40618-025-02619-z","article-title":"Evaluation of bone density and microstructure by DXA, TBS and HR-pQCT: an assessment of cortical porosity and its association with vertebral fractures in patients with acromegaly","volume":"48","author":"Ornellas","year":"2025","journal-title":"J Endocrinol Invest"},{"issue":"12","key":"2026093004253327800_lvag178-B62","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.1210\/jc.2008-0791","article-title":"Prevalence of vertebral fractures in men with acromegaly","volume":"93","author":"Mazziotti","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026093004253327800_lvag178-B63","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1210\/er.2018-00005","article-title":"Pituitary diseases and bone","volume":"39","author":"Mazziotti","year":"2018","journal-title":"Endocr Rev"},{"issue":"1","key":"2026093004253327800_lvag178-B64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086757","article-title":"Sex and genetic factors determine osteoblastic differentiation potential of murine bone marrow stromal cells","volume":"9","author":"Zanotti","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"2026093004253327800_lvag178-B65","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvae153","article-title":"Sexual dimorphism in the musculoskeletal system: sex hormones and beyond","volume":"8","author":"Plotkin","year":"2024","journal-title":"J Endocr Soc"},{"issue":"1","key":"2026093004253327800_lvag178-B66","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s12020-011-9486-x","article-title":"Influence of diabetes mellitus on vertebral fractures in men with acromegaly","volume":"40","author":"Mazziotti","year":"2011","journal-title":"Endocrine"},{"issue":"1","key":"2026093004253327800_lvag178-B67","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1530\/eje-10-0125","article-title":"Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency","volume":"163","author":"Mazziotti","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"2026093004253327800_lvag178-B68","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa363","article-title":"Treatment of acromegalic osteopathy in real-life clinical practice: the BAAC (bone active drugs in acromegaly) study","volume":"105","author":"Mazziotti","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026093004253327800_lvag178-B69","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1210\/clinem\/dgad493","article-title":"Cholecalciferol use is associated with a decreased risk of incident morphometric vertebral fractures in acromegaly","volume":"109","author":"Chiloiro","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026093004253327800_lvag178-B70","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/cen.12262","article-title":"FRAX score in acromegaly: does it tell the whole story?","volume":"80","author":"Brzana","year":"2014","journal-title":"Clin Endocrinol"},{"issue":"3","key":"2026093004253327800_lvag178-B71","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s12020-024-03863-8","article-title":"DXA-derived lumbar bone strain index corrected for kyphosis is associated with vertebral fractures and trabecular bone score in acromegaly","volume":"85","author":"Jaafar","year":"2024","journal-title":"Endocrine"},{"issue":"7","key":"2026093004253327800_lvag178-B72","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvag135","article-title":"Bone and joint quality remains impaired in long-term controlled acromegaly: an HR-pQCT study","volume":"10","author":"Rosendal","year":"2026","journal-title":"J Endocr Soc"},{"issue":"5","key":"2026093004253327800_lvag178-B73","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1210\/jc.2004-2297","article-title":"Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life","volume":"90","author":"Biermasz","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026093004253327800_lvag178-B74","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/ejendo\/lvag045","article-title":"Distribution, severity, and management of joint pain in patients with acromegaly","volume":"194","author":"Kyriakakis","year":"2026","journal-title":"Eur J Endocrinol"},{"issue":"Supplement_1","key":"2026093004253327800_lvag178-B75","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.1210\/clinem\/dgag122","article-title":"The acromegaly patient experience: burden of treatment and quality of life","volume":"111","author":"Geer","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026093004253327800_lvag178-B76","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1210\/jcem.83.6.4865","article-title":"Reversibility of joint thickening in acromegalic patients: an ultrasonography study","volume":"83","author":"Colao","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026093004253327800_lvag178-B77","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1046\/j.1365-2265.1999.00851.x","article-title":"Ultrasonographic evidence of joint thickening reversibility in acromegalic patients treated with lanreotide for 12 months","volume":"51","author":"Colao","year":"1999","journal-title":"Clin Endocrinol"},{"issue":"1","key":"2026093004253327800_lvag178-B78","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1530\/eje.0.1480031","article-title":"Twelve months of treatment with octreotide-LAR reduces joint thickness in acromegaly","volume":"148","author":"Colao","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026093004253327800_lvag178-B79","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1530\/eje-08-0845","article-title":"High prevalence of arthropathy, according to the definitions of radiological and clinical osteoarthritis, in patients with long-term cure of acromegaly: a case-control study","volume":"160","author":"Wassenaar","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026093004253327800_lvag178-B80","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1530\/eje-11-0795","article-title":"Automated image analysis of hand radiographs reveals widened joint spaces in patients with long-term control of acromegaly: relation to disease activity and symptoms","volume":"166","author":"Biermasz","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2026093004253327800_lvag178-B81","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1530\/eje-16-1073","article-title":"Acromegalic arthropathy in various stages of the disease: an MRI study","volume":"176","author":"Claessen","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2026093004253327800_lvag178-B82","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1007\/s11102-022-01233-z","article-title":"Clinical and radiographic assessment of peripheral joints in controlled acromegaly","volume":"25","author":"Pelsma","year":"2022","journal-title":"Pituitary"},{"issue":"6","key":"2026093004253327800_lvag178-B83","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s11102-019-00991-7","article-title":"The acromegalic spine: fractures, deformities and spinopelvic balance","volume":"22","author":"Azevedo Oliveira","year":"2019","journal-title":"Pituitary"},{"issue":"3","key":"2026093004253327800_lvag178-B84","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/jbmr.3669","article-title":"The radiology of osteoporotic vertebral fractures revisited","volume":"34","author":"Lentle","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2026093004253327800_lvag178-B85","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s11102-025-01573-6","article-title":"Acromegaly treatment and bone: a bidirectional relationship","volume":"28","author":"Chiloiro","year":"2025","journal-title":"Pituitary"},{"issue":"3","key":"2026093004253327800_lvag178-B86","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11102-024-01398-9","article-title":"Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot single center experience","volume":"27","author":"Chiloiro","year":"2024","journal-title":"Pituitary"},{"issue":"6","key":"2026093004253327800_lvag178-B87","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s40618-023-02281-3","article-title":"The direct impact of pegvisomant on osteoblast functions and bone development","volume":"47","author":"Vitali","year":"2024","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"2026093004253327800_lvag178-B88","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s40618-022-01740-7","article-title":"Direct effects of octreotide on osteoblast cell proliferation and function","volume":"45","author":"Vitali","year":"2022","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2026093004253327800_lvag178-B89","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz054","article-title":"Effects of pegvisomant and pasireotide LAR on vertebral fractures in acromegaly resistant to first-generation SRLs","volume":"105","author":"Chiloiro","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026093004253327800_lvag178-B90","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11102-025-01630-0","article-title":"Long-term effect on bone mineral density of denosumab in the treatment of hyperpituitarism driven osteoporosis: an exploratory study","volume":"29","author":"Chiloiro","year":"2026","journal-title":"Pituitary"},{"issue":"2","key":"2026093004253327800_lvag178-B91","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1530\/eje-16-0340","article-title":"Treatment of acromegaly increases BMD but reduces trabecular bone score: a longitudinal study","volume":"175","author":"Godang","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2026093004253327800_lvag178-B92","doi-asserted-by":"publisher","first-page":"4808","DOI":"10.1210\/jc.2013-2695","article-title":"Progression of vertebral fractures despite long-term biochemical control of acromegaly: a prospective follow-up study","volume":"98","author":"Claessen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026093004253327800_lvag178-B93","doi-asserted-by":"publisher","first-page":"K37","DOI":"10.1093\/ejendo\/lvae016","article-title":"Long-term depot specific changes in adipose tissue after treatment of acromegaly","volume":"190","author":"Falch","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2026093004253327800_lvag178-B94","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s11102-024-01465-1","article-title":"Approach to the patient with controlled acromegaly and acromegalic arthropathy: clinical diagnosis and management","volume":"27","author":"Pelsma","year":"2024","journal-title":"Pituitary"},{"issue":"5","key":"2026093004253327800_lvag178-B95","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1210\/clinem\/dgab874","article-title":"State of the art of patient-reported outcomes in acromegaly or GH deficiency: a systematic review and meta-analysis","volume":"107","author":"van der Meulen","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026093004253327800_lvag178-B96","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1007\/s12020-024-03813-4","article-title":"The effect of coping strategies on health-related quality of life in acromegaly patients","volume":"84","author":"Schock","year":"2024","journal-title":"Endocrine"},{"issue":"8","key":"2026093004253327800_lvag178-B97","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s00264-022-05447-5","article-title":"Clinical and functional outcome of total hip arthroplasty in patients with acromegaly: mean twelve year follow-up","volume":"46","author":"Akkaya","year":"2022","journal-title":"Int Orthop"},{"key":"2026093004253327800_lvag178-B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2024.117296","article-title":"Mechanical complications and revision following total joint arthroplasty in acromegalic patients: a nationwide US-based study","volume":"190","author":"Ghaseminejad-Raeini","year":"2025","journal-title":"Bone"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvag178\/71079396\/lvag178.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/195\/3\/R97\/71079396\/lvag178.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/195\/3\/R97\/71079396\/lvag178.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:25:59Z","timestamp":1790756759000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/195\/3\/R97\/8794455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":98,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvag178","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,8,28]]}}}